NCT02054754View on ClinicalTrials.gov

Assessment of Single Doses of Oral Dexanabinol in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions

SafetyTolerabilityPharmacokineticsCancer

Interventions

DRUG

Dexanabinol Dose Level 1

Oral formulation of dexanabinol

DRUG

Dexanabinol Dose Level 2

Oral formulation of dexanabinol

DRUG

Dexanabinol Dose Level 3

Oral formulation of dexanabinol

DRUG

Dexanabinol Dose Level 4

Oral formulation of dexanabinol

DRUG

Dexanabinol Dose Level 5

Oral formulation of dexanabinol

DRUG

Placebo

Trial Locations (1)

NG11 6JS

Quotient Clinical, Nottingham

All Listed Sponsors

lead

e-Therapeutics PLC

INDUSTRY

NCT02054754 - Assessment of Single Doses of Oral Dexanabinol in Healthy Subjects | Biotech Hunter | Biotech Hunter